Finch Therapeutics Group's total assets for Q1 2024 were $50.09M, a decrease of -15.80% from the previous quarter. FNCH total liabilities were $31.05M for the fiscal quarter, a -7.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.